CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 750 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02726698
NCT02726698N/ACompleted

Reappraisal of Atrial Fibrillation: Interaction Between HyperCoagulability, Electrical Remodeling, and Vascular Destabilisation in the Progression of Atrial Fibrillation - An Observational Exploratory Study on Pathophysiological Mechanisms of AF Progression and on the Role of LinQ/CareLink Guided Patient Tailored Therapy in Patients With Atrial Fibrillation

University Medical Center Groningen·observational·Posted Apr 4, 2016·Updated Dec 6, 2024

In Brief

An observational study for Atrial Fibrillation. Completed, enrolled 750 participants across 9 sites.

Detailed Summary

The purpose of this study is to study clinical factors and (blood) biomarkers related to progression of Atrial Fibrillation (AF) in patients diagnosed with self-terminating AF with special reference to hypercoagulability. All patients will be continuously monitored for their atrial rhythm to assess AF progression, either through an implantable loop recorder (Reveal LinQ) or via the atrial lead of a cardiac implantable electronic device (CIED), both in combination with the CareLink home monitoring system. Remote monitoring and interrogation will be installed and used on a daily basis.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesNetherlands

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 4, 2016
Enrollment StartJul 1, 2016
Primary CompletionOct 1, 2024
TodayJul 2, 2026
Enrollment to primary: 8.3 yearsPosted 10.2 years ago